Matches in Wikidata for { <http://www.wikidata.org/entity/Q64077758> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q64077758 description "article by Marina Baretti et al published March 2019 in Hepatobiliary surgery and nutrition" @default.
- Q64077758 description "im März 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64077758 description "wetenschappelijk artikel" @default.
- Q64077758 description "наукова стаття, опублікована в березні 2019" @default.
- Q64077758 name "AB049. P-17. A phase II study of HDAC inhibition to sensitize to immunotherapy in advanced cholangiocarcinoma" @default.
- Q64077758 name "AB049. P-17. A phase II study of HDAC inhibition to sensitize to immunotherapy in advanced cholangiocarcinoma" @default.
- Q64077758 type Item @default.
- Q64077758 label "AB049. P-17. A phase II study of HDAC inhibition to sensitize to immunotherapy in advanced cholangiocarcinoma" @default.
- Q64077758 label "AB049. P-17. A phase II study of HDAC inhibition to sensitize to immunotherapy in advanced cholangiocarcinoma" @default.
- Q64077758 prefLabel "AB049. P-17. A phase II study of HDAC inhibition to sensitize to immunotherapy in advanced cholangiocarcinoma" @default.
- Q64077758 prefLabel "AB049. P-17. A phase II study of HDAC inhibition to sensitize to immunotherapy in advanced cholangiocarcinoma" @default.
- Q64077758 P1433 Q64077758-3C23CF89-F120-49D5-A276-4CA6109A956F @default.
- Q64077758 P1476 Q64077758-42BB7E47-72C5-43E3-B4BE-8A925DF5F1EF @default.
- Q64077758 P2093 Q64077758-01A4ABD6-AE4C-468B-8B9D-1625DEC7E844 @default.
- Q64077758 P2093 Q64077758-0F6A7C40-5FC3-449C-84C4-876F71DB386B @default.
- Q64077758 P2093 Q64077758-634689CB-CE9E-47A3-BFAB-CB725E973923 @default.
- Q64077758 P2093 Q64077758-6F231D02-F639-4086-A16D-0A2F53258155 @default.
- Q64077758 P2093 Q64077758-75A3B8B9-C008-4EEE-AC49-8ED9C90B9062 @default.
- Q64077758 P2093 Q64077758-E5A76E94-0B80-4935-AA52-C9C81E428FD3 @default.
- Q64077758 P304 Q64077758-59416F98-4CA7-40B5-925D-246920236E7E @default.
- Q64077758 P31 Q64077758-C37ACB1B-7799-4087-AF9A-1F90FA5E27A0 @default.
- Q64077758 P356 Q64077758-913B4A61-B341-44F6-9368-4625E33FE86C @default.
- Q64077758 P433 Q64077758-A71379CE-BBF1-4A48-A927-D2467E8AE8FB @default.
- Q64077758 P478 Q64077758-61D769A6-C723-4FA7-932B-9DE70A37F098 @default.
- Q64077758 P50 Q64077758-BD7AD949-B4BF-4962-8AAE-D63181DA9C7E @default.
- Q64077758 P577 Q64077758-50495CDF-C7F6-4EEA-B8B1-E70A7ED3034B @default.
- Q64077758 P921 Q64077758-35BCB0DD-AB80-46DC-AFE0-4EF52FC3E60B @default.
- Q64077758 P921 Q64077758-E1CED6DB-727A-49EA-8AE3-51BA05F2D639 @default.
- Q64077758 P932 Q64077758-EE3142FD-B0C4-49B9-B328-6E9E730406BB @default.
- Q64077758 P356 HBSN.2019.AB049 @default.
- Q64077758 P1433 Q26842328 @default.
- Q64077758 P1476 "AB049. P-17. A phase II study of HDAC inhibition to sensitize to immunotherapy in advanced cholangiocarcinoma" @default.
- Q64077758 P2093 "Brian Christmas" @default.
- Q64077758 P2093 "Jennifer Durham" @default.
- Q64077758 P2093 "Leslie Cope" @default.
- Q64077758 P2093 "Marina Baretti" @default.
- Q64077758 P2093 "Nilofer S. Azad" @default.
- Q64077758 P2093 "Rosalind Walker" @default.
- Q64077758 P304 "AB049-AB049" @default.
- Q64077758 P31 Q13442814 @default.
- Q64077758 P356 "10.21037/HBSN.2019.AB049" @default.
- Q64077758 P433 "S1" @default.
- Q64077758 P478 "8" @default.
- Q64077758 P50 Q29452184 @default.
- Q64077758 P577 "2019-03-01T00:00:00Z" @default.
- Q64077758 P921 Q124292 @default.
- Q64077758 P921 Q1427096 @default.
- Q64077758 P932 "6421164" @default.